Evaluation of the newer amebacides.
D000562:Amebiasis / Q000628:therapy*; D000563:Amebicides; D000981:Antiprotozoal Agents; D001152:Arsenicals / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use*; D002751:Chlortetracycline / Q000627:therapeutic use*; D004404:Dysentery, Amebic; D010118:Oxytetracycline / Q000627:therapeutic use*
D000563:Amebicides; D000981:Antiprotozoal Agents; D001152:Arsenicals; D002701:Chloramphenicol; D001729:Bismuth; D002751:Chlortetracycline; D010118:Oxytetracycline
AMEBIASIS/therapy; AUREOMYCIN/therapeutic use; BISMUTH-ARSENIC COMPOUNDS/therapeutic use; CHLORAMPHENICOL/therapeutic use; OXYTETRACYCLINE/therapeutic use